SABS — SAB Biotherapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapNeutral

Annual balance sheet for SAB Biotherapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	R2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	33.2	15	56.6	20.8	96.6
Net Total Accounts Receivable
Net Total Receivables	8.01	5.56	0	0.055	0.947
Prepaid Expenses
Total Other Current Assets
Total Current Assets	50.2	22.1	58.9	23.8	101
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	30.9	28.3	24.7	19.9	19.4
Long Term Investments
Other Long Term Assets
Total Assets	81.1	50.9	83.9	44.2	173
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	26.5	15	10.8	7.98	10.7
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	42.6	19.8	26.6	18.2	21.3
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	38.5	31.1	57.3	26	151
Total Liabilities & Shareholders' Equity	81.1	50.9	83.9	44.2	173
Total Common Shares Outstanding